Form 4 for TRAW Traws Pharma, Inc.
Accepted 2022-01-24 00:00:00 ET · period of report 2022-01-21 · accession 0001179110-22-000564 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-24 | 2022-01-21 | TRAW | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | P - Purchase | $2.02 | +1,500 | 23.0K | +7% | +$3,030 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-21 | P | A | 1,500 | $2.02 | 23,014 | D | — | — | (F2) Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. |